ATLAS – Joint PhD Program from BioNTech and TRON | 9 Fully funded PhD Positions

ATLAS is a joint PhD program by BioNTech and TRON (Translational Oncology Mainz), which are the leading immunotherapy institutions. Their joint international PhD program is seeking talented graduates as junior researchers from all nations.

ATLAS is a joint PhD program by BioNTech and TRON (Translational Oncology Mainz), which are the leading immunotherapy institutions. Their joint international PhD program is seeking talented graduates as junior researchers from all nations.

Their PhD program focuses on translational medicine with experienced faculties, they provide a supportive environment for the scholars to conduct cutting-edge research projects.

ATLAS is offering 9 PhD positions in biology, life science, biochemistry, chemistry, medicine, and computer science or related areas.

Benefits of joining ATLAS

1. Collaborative interdisciplinary research between academia and pharmaceutical

2. Opportunity to publish your research work in top journals.

3. Doctoral degree from their parenting university

Who can apply?

  1. You should hold an M.Sc. degree or equivalent.
  2. You should have a strong passion for science.
  3. You are able to work well in an international, multi-disciplinary team and also capable of working independently.
  4. Professional proficiency in both written and spoken English]

Read carefully the instructions before applying.

Also Check: The University of Edinburgh, Scotland – PhD Openings – September 2023

Projects offered

Project NumberTitle of the projectUnit/Location
P01Targeting metastasizing tumor cells for the prevention of metastasis (MTC-target)Therapeutic cardiology (Mainz, Germany)
P02RNA-based modulation of iPSC-derived cardiomyocytes for heart repair (RiPS-Cardio)Therapeutic cardiology (Mainz, Germany)
P03Functional characterization of a novel uveal melanoma targetExpression and cell biology (Mainz, Germany)
P04Metabolism Directed Cancer Immunotherapy (MERCI)Immunotherapies and Preclinical Research: Cancer Vaccines (Mainz, Germany)
P05Development of the circular RNA platform for protein expressionRNA Optimization & Internal Contract Synthesis (Mainz, Germany)
P06Generation and engineering of a mRNA-encoded broadly neutralizing antibody cocktail against HIVBiMAB & IDV (Mainz, Germany)
P07Whole-Genome Sequencing and individualised cancer treatmentBioinformatics (Mainz, Germany)
P08Development of an mRNA firetruck to promote multi-targeted individualized mRNA therapy for chronic pain recoveryInflammation and Tissue Damage (Mainz, Germany)
P09Optimizing mRNA sequence design by combining data mining from nature with novel algorithmic approaches (OptiRNA)RNA Biochemistry and CMC Development (Mainz, Germany)
atlas-phdprogram.com/projects-offered

Deadline: October 31st 2023

Interviews: Pre-selected candidates will be invited to Mainz, Germany for two-day interviews


Published: 18-September-2023

Updated: 19-September-2023, 23:11

Editor's Desk

Next Post

Amplified Fragment Length Polymorphism - AFLP | Explained

Tue Sep 19 , 2023
Amplified fragment length polymorphism PCR is a PCR-based tool used in genetics research, DNA fingerprinting and in the practice of genetic engineering. In short, AFLP is an intermediate stage between RFLP and PCR.
Amplified Fragment Length Polymorphism - AFLP | Explained

Related Articles